Fe3 Medical concludes first human study of iontophoretic transdermal technology

10:48 EDT 15 Apr 2019 | Compelo Medical Devices

Fe3 Medical has developed the alternative therapy for the patients who suffer from devastating effects of iron deficiency anemia, but cannot tolerate the available oral therapies. The human

More From BioPortfolio on "Fe3 Medical concludes first human study of iontophoretic transdermal technology"